Literature DB >> 31405774

Metformin as Anti-Aging Therapy: Is It for Everyone?

Alexander A Soukas1, Haibin Hao2, Lianfeng Wu3.   

Abstract

Metformin is the most widely prescribed oral hypoglycemic medication for type 2 diabetes worldwide. Metformin also retards aging in model organisms and reduces the incidence of aging-related diseases such as neurodegenerative disease and cancer in humans. In spite of its widespread use, the mechanisms by which metformin exerts favorable effects on aging remain largely unknown. Further, not all individuals prescribed metformin derive the same benefit and some develop side effects. Before metformin finds its way to mainstay therapy for anti-aging, a more granular understanding of the effects of the drug in humans is needed. This review provides an overview of recent findings from metformin studies in aging and longevity and discusses the use of metformin to combat aging and aging-related diseases.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  aging; lysosome; metformin; mitochondria; personalized medicine; type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31405774      PMCID: PMC6779524          DOI: 10.1016/j.tem.2019.07.015

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  48 in total

1.  Metformin alleviates intestinal epithelial barrier damage by inhibiting endoplasmic reticulum stress-induced cell apoptosis in colitis cell model.

Authors:  Jingang Wang; Chunxiao Chen; Yuhan Ren; Xinxin Zhou; Shan Yu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-25

Review 2.  Redox Homeostasis Involvement in the Pharmacological Effects of Metformin in Systemic Lupus Erythematosus.

Authors:  Xiangyu Teng; Josephine Brown; Laurence Morel
Journal:  Antioxid Redox Signal       Date:  2022-01-04       Impact factor: 8.401

3.  A model of metformin mitochondrial metabolism in metachromatic leukodystrophy: first description of human Schwann cells transfected with CRISPR-Cas9.

Authors:  Nayibe Tatiana Sanchez-Álvarez; Paula Katherine Bautista-Niño; Juanita Trejos-Suárez; Norma Cecilia Serrano-Díaz
Journal:  Open Biol       Date:  2022-07-06       Impact factor: 7.124

4.  Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease.

Authors:  Fang-Fang Cheng; Yan-Li Liu; Jang Du; Jun-Tang Lin
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

Review 5.  Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs.

Authors:  Carolin Thomas; Lia Wurzer; Ernst Malle; Michael Ristow; Corina T Madreiter-Sokolowski
Journal:  Front Aging       Date:  2022-06-14

Review 6.  Benefits of Metformin in Attenuating the Hallmarks of Aging.

Authors:  Ameya S Kulkarni; Sriram Gubbi; Nir Barzilai
Journal:  Cell Metab       Date:  2020-04-24       Impact factor: 27.287

7.  Determination of metformin bio-distribution by LC-MS/MS in mice treated with a clinically relevant paradigm.

Authors:  Kiran Chaudhari; Jianmei Wang; Yong Xu; Ali Winters; Linshu Wang; Xiaowei Dong; Eric Y Cheng; Ran Liu; Shao-Hua Yang
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

8.  Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis.

Authors:  Fan Ping; Ning Jiang; Yuxiu Li
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

Review 9.  The use of DNA methylation clock in aging research.

Authors:  Xi He; Jiaojiao Liu; Bo Liu; Jingshan Shi
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-11

10.  Metformin Reverses Hashimoto's Thyroiditis by Regulating Key Immune Events.

Authors:  Xi Jia; Tianyu Zhai; Chunjie Qu; Jianjun Ye; Jing Zhao; Xuerong Liu; Jin-An Zhang; Qiaohui Qian
Journal:  Front Cell Dev Biol       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.